1. UNDERSTANDING THE TECHNOLOGY> Recent Patents on MicroRNA-Induced Pluripotent Stem Cell Generation

  2. Chanel reveals role of microRNAs in skin ageing

  3. Regulation of somatic cell reprogramming through inducible miRNA expression

  4. MicroRNA Inhibits the Tumorigenecity of Human Pluripotent Stem Cells

  5. MiRNA reprograms human skin cancer cells into a pluripotent ES-cell-like state

  6. Chapter 4 from Current Perspectives in microRNAs

  7. Highly Efficient miRNA-Mediated Reprogramming

  8. MicroRNA Inhibits the Tumorigenecity of Human Pluripotent Stem Cells

  9. MicroRNAs and their roles in wound repair and regeneration

  1. Chang-Lin S, Hung A, Chang DC, Lin YW, Ying SY and Lin SL (2016). “Novel glycylated sugar alcohols protect ESC-specific microRNAs from degradation in iPS cells.” Nucleic Acids Res 44(10): 4894-906.

  2. Deng JH, Deng P, Lin SL and Ying SY (2015). “Gene silencing in vitro and in vivo using intronic microRNAs.” Methods Mol Biol 1218: 321-40.

  3.  Chen JS and Wu DT (2013). “Application of intronic microRNA agents in cosmetics.” Methods Mol Biol. 936: 325-41.

  4. Chen JS and Lin SL (2013). “Recent patents on microRNA-induced pluripotent stem cell generation.” Recent Patents on Regenerative Medicine 3: 5-16.

  5. Lin SL and Ying SY (2013). “Mechanism and method for generating tumor-free iPS cells using intronic microRNA miR-302 induction.” Methods Mol Biol 936: 295-312.

  6. Kelley K and Lin SL (2012). “Induction of somatic cell reprogramming using the microRNA miR-302.” Prog Mol Biol Trasl Sci 111: 83-107.

  7. Lin SL (2011). “Concise review: deciphering the mechanism behind induced pluripotent stem cell generation.” Stem Cells 11: 1645-9.

  8. Lin SL, Chang DC, Lin CH, Ying SY, Leu D and Wu DT (2011). “Regulation of somatic cell reprogramming through inducible mir-302 expression.” Nucleic Acids Res 39(3): 1054-65.

  9. Lin SL, Chang DC, Ying SY, Leu D and Wu DT (2010). “MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways.” Cancer Res 22: 9473-82.

  10. Chen JS, Leu D, Wu DT and Lin SL (2009). “MicroRNA-mediated skin lightening: an innovative cosmetic approach.” H&PC Today 2: 8-10.

  11.  Wu DTS, Chen JS, Chang DC and Lin SL (2008). “Mir-434-5p mediates skin whitening and lightening.” Clinical, Cosmetic and Investigational Dermatology 1: 19-35.

  12. Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT and Ying SY (2008). “Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.” RNA 14(10):2115-24.

  13. Lin SL and Chen J; Mechanism of miR‐302‐mediated iPS cell generation. Sell S (Ed.) Stem Cells Handbook. (in press). Springer Publishers press, New York, 2012. 

  14. Kelley K, Chang SJE, Lin SL; Mechanism of repeat‐associated microRNAs in fragile X syndrome. Neural Plasticity (in press), 2012. 

  15. Lin SL, Chen SKJ; Recent patents on microRNA‐induced pluripotent stem cell generation. Recent Patents on Regenerative Medicine (in press), 2012. 

  16. Lin SL; Deciphering the mechanism behind induced pluripotent stem cell generation. Stem Cells 29: 1645‐1649, 2011. 

  17. Lin SL, Chang D, Lin CH, Ying SY, Leu D and Wu DTS; Regulation of somatic cell reprogramming through inducible mir‐ 302 expression. Nucleic Acids Res. 39: 1054‐1065, 2011. 

  18. Lin SL, Chang D, Ying SY, Leu D and Wu DTS; MicroRNA miR‐302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of CDK2 and CDK4/6 cell cycle pathways. Cancer Res. 70: 9473‐9482, 2010. 

  19. Ying SY, Chang CP and Lin SL; Intron‐mediated RNA interference, intronic microRNAs, and applications. Methods Mol Biol. 629: 205‐237, 2010. 

  20. Ying SY and Lin SL; Intron‐mediated RNA interference and microRNA biogenesis. Methods Mol Biol. 487: 387‐413, 2009. 

  21. Chang SJE, Chang‐Lin S, Chang D, Ying SY and Lin SL; Repeat‐associated microRNA triggers fragile X syndrome in zebrafish. The Open Neuropsycho‐pharmacology J. 1: 6‐ 18, 2008. 

  22. Lin SL, ChangD, Chang‐Lin S, Lin CH, Wu DTS, Chen DT and Ying SY; Mir‐302 reprograms human skin cancer cells into a pluripotent ES‐cell‐like state. RNA 14: 2115‐2124, 2008. 

  23. Ying SY, Chang D and Lin SL; The microRNA (miRNA): Overview of the RNA gene that modulates gene functions. Mol Biotechnol. 38: 257‐268, 2008. 

  24. Lin SL, Kim H and Ying SY; Intron‐mediated RNA interference and microRNA (miRNA). Front. Biosci. 13: 2216‐2230, 2008. 

  25. Lin SL, Jiang A, Chang D, and Ying SY; Loss of mir‐146a function in hormone‐ refractory prostate cancer. RNA 14: 417‐ 424, 2008. 

  26. Lin SL, Chang D, Jiang A and Ying SY; Androgen receptor regulates CD168 expression and signaling in prostate cancer. Carcinogenesis 29: 282‐290, 2008. 

  27. Lin SL, Chang D and Ying SY; Hyaluronan stimulates transformation of androgen‐ independent prostate cancer. Carcinogenesis 28: 310‐320, 2007. 

Relevant Papers & Articles

Relevant Papers & Articles

Other Related Publications